mitochondrial disease

YOKOHAMA, Japan, July 28, 2026 AGC Biologics has signed a long-term commercial manufacturing agreement valued at hundreds of millions...

ROSWELL, Ga., DUBLIN, Ireland, and HAMILTON, Bermuda, July 28, 2026 Saol Therapeutics has announced that the U.S. Food and...

Berlin, Germany | July 21, 2026 OMEICOS announced that the U.S. Food and Drug Administration (FDA) has provided positive...

BOSTON, June 22, 2026 Mighty Therapeutics, formerly known as Stealth BioTherapeutics, has officially announced its corporate rebranding, marking a...

NEW YORK, N.Y., June 16, 2026 The Clinical Trials on Alzheimer’s Disease (CTAD) Conference and the Alzheimer’s Drug Discovery...

BRUSSELS, Belgium, June 17, 2026 UCB has announced the publication of two significant peer-reviewed studies in Brain Communications demonstrating...

NIJMEGEN, The Netherlands, April 16, 2026 Khondrion has announced a significant clinical milestone with the first patient dosed in...